While the expression of other candidates, including RORA, RORC, and THRB, remained unchanged, that of PPARA significantly decreased as NAFLD progressed to steatosis and NASH, and showed a negative correlation with that of MIR20B (Figure 2—figure supplement 3). The gene discussed is RORA; the disease is metabolic dysfunction-associated steatohepatitis.